On 30 November 2012, the final stage in the transformation from Nycomed Australia to Takeda Australia was completed, with the Company operating officially under the name Takeda Pharmaceuticals Australia Pty Ltd.
The Nycomed history in Australia dates back to 2001 and globally it stretches back to Norway in 1874 when the Company was an agent of foreign pharmaceutical products. Nycomed was acquired by Takeda in October 2011.
Takeda, with a long and rich history spanning 231 years, is Japan’s largest pharmaceutical company and the 12th largest worldwide. Takeda’s mission is to ‘strive towards better health for people worldwide through leading innovation in medicine.’ To achieve this goal, the Company is pursuing new drug discovery that overcomes the barriers to technical innovation currently seen in the pharmaceutical industry in order to develop a strong pipeline of products that offer outstanding efficacy and safety for people worldwide.